LACDR

Universiteit Leiden

List
Filter

Found 15 results. Export: Tagged | XML

Filters: keyword is Antipyrine [Clear All Filters]

1991

De Boer, A., Stiekema, J.C., Danhof, M., Breimer, D.D. , The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172, Br J Clin Pharmacol, vol. 32, no. 1, pp. 23-9.

1989

van Bree, J.B., Baljet, A.V., van Geyt, A., de Boer, A.G., Danhof, M., Breimer, D.D. , The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system, J Pharmacokinet Biopharm, vol. 17, no. 4, pp. 441-62.

1988

Schellens, J.H., van der Wart, J.H., Danhof, M., van der Velde, E.A., Breimer, D.D. , Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach, Br J Clin Pharmacol, vol. 26, no. 4, pp. 373-84.

1987

Posner, J., Danhof, M., Teunissen, M.W., Breimer, D.D., Whiteman, P.D. , The disposition of antipyrine and its metabolites in young and elderly healthy volunteers, Br J Clin Pharmacol, vol. 24, no. 1, pp. 51-5.

1982

Danhof, M., Verbeek, R.M., van Boxtel, C.J., Boeijinga, J.K., Breimer, D.D. , Differential effects of enzyme induction on antipyrine metabolite formation, Br J Clin Pharmacol, vol. 13, no. 3, pp. 379-86.

Danhof, M., Teunissen, M.W., Breimer, D.D. , 3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance, Pharmacology, vol. 24, no. 3, pp. 181-4.

Danhof, M., van Zuilen, A., Boeijinga, J.K., Breimer, D.D. , Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time, Eur J Clin Pharmacol, vol. 21, no. 5, pp. 433-41.

1981

Danhof, M., Idle, J.R., Teunissen, M.W., Sloan, T.P., Breimer, D.D., Smith, R.L. , Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation, Pharmacology, vol. 22, no. 6, pp. 349-58.

1980

Buchanan, N., Davis, M., Danhof, M., Breimer, D.D. , Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery, Br J Clin Pharmacol, vol. 10, no. 4, pp. 363-8.

Van Boxtel, C.J., Breimer, D.D., Danhof, M. , Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings], Br J Pharmacol, vol. 68, no. 1, pp. 121P.

1979

Danhof, M., Krom, D.P., Breimer, D.D. , Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment, Xenobiotica, vol. 9, no. 11, pp. 695-702.

Danhof, M., Breimer, D.D. , Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers, Br J Clin Pharmacol, vol. 8, no. 6, pp. 529-37.

Danhof, M., de Boer, A.G., de der Groot-van Vis, E., Breimer, D.D. , Assay of 3-carboxy-antipyrine in urine by capillary gas chromatography with nitrogen selective detection. Some preliminary results in man, Pharmacology, vol. 19, no. 4, pp. 215-20.

Danhof, M., der Groot-van Vis, E., Breiner, D.D. , Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man, Pharmacology, vol. 18, no. 4, pp. 210-23.

1978

Danhof, M., Breimer, D.D. , Therapeutic drug monitoring in saliva, Clin Pharmacokinet, vol. 3, no. 1, pp. 39-57.

LACDR